152 related articles for article (PubMed ID: 22778155)
21. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
[TBL] [Abstract][Full Text] [Related]
22. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells.
Ma DF; Kondo T; Nakazawa T; Niu DF; Mochizuki K; Kawasaki T; Yamane T; Katoh R
Hum Pathol; 2010 Nov; 41(11):1550-7. PubMed ID: 20619442
[TBL] [Abstract][Full Text] [Related]
24. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer.
Cole C; Lau S; Backen A; Clamp A; Rushton G; Dive C; Hodgkinson C; McVey R; Kitchener H; Jayson GC
Cancer Biol Ther; 2010 Sep; 10(5):495-504. PubMed ID: 20595807
[TBL] [Abstract][Full Text] [Related]
26. GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling.
Bai A; Meetze K; Vo NY; Kollipara S; Mazsa EK; Winston WM; Weiler S; Poling LL; Chen T; Ismail NS; Jiang J; Lerner L; Gyuris J; Weng Z
Cancer Res; 2010 Oct; 70(19):7630-9. PubMed ID: 20709759
[TBL] [Abstract][Full Text] [Related]
27. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
[TBL] [Abstract][Full Text] [Related]
28. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion.
Knuchel S; Anderle P; Werfelli P; Diamantis E; Rüegg C
Oncotarget; 2015 Jun; 6(16):14300-17. PubMed ID: 25973543
[TBL] [Abstract][Full Text] [Related]
30. The IIIc alternative of Fgfr2 is a positive regulator of bone formation.
Eswarakumar VP; Monsonego-Ornan E; Pines M; Antonopoulou I; Morriss-Kay GM; Lonai P
Development; 2002 Aug; 129(16):3783-93. PubMed ID: 12135917
[TBL] [Abstract][Full Text] [Related]
31. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer.
Nomura S; Yoshitomi H; Takano S; Shida T; Kobayashi S; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Miyazaki M
Br J Cancer; 2008 Jul; 99(2):305-13. PubMed ID: 18594526
[TBL] [Abstract][Full Text] [Related]
32. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
33. FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.
Mathur A; Ware C; Davis L; Gazdar A; Pan BS; Lutterbach B
PLoS One; 2014; 9(6):e98515. PubMed ID: 24968263
[TBL] [Abstract][Full Text] [Related]
34. Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor Activity.
Yin Y; Djakovic S; Marsters S; Tien J; Peng J; Tremayne J; Lee G; Neve RM; Wu Y; Merchant M; Ashkenazi A; Carter PJ
Mol Cancer Ther; 2015 Oct; 14(10):2270-8. PubMed ID: 26269606
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
[TBL] [Abstract][Full Text] [Related]
36. Proliferative, infiltrative, and metastatic activities in colorectal tumors assessed by MIB-1 antibody.
Ishida H; Sadahiro S; Suzuki T; Ishikawa K; Kamijo A; Tajima T; Makuuchi H; Murayama C
Oncol Rep; 2003; 10(6):1741-5. PubMed ID: 14534689
[TBL] [Abstract][Full Text] [Related]
37. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
[TBL] [Abstract][Full Text] [Related]
39. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
40. Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cells.
Koneczny I; Schulenburg A; Hudec X; Knöfler M; Holzmann K; Piazza G; Reynolds R; Valent P; Marian B
Mol Carcinog; 2015 Sep; 54(9):789-799. PubMed ID: 24619956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
